A case/non-case study of a national pharmacovigilance database to explore drug-induced acute kidney injury
This study highlights the importance of clinical pharmacy activities in closely monitoring renal function of people with known risk factors or those prescribed medications known to increase the risk of AKI. Some of the medications identified require further investigation to validate their association with AKI.
Authors
- Filipa Alves da Costa (ORCID: https://orcid.org/0000-0003-0562-2514)
- Filipa Duarte‐Ramos (ORCID: https://orcid.org/0000-0001-6632-2553)
- Fernando Fernández-Llimós (ORCID: https://orcid.org/0000-0002-8529-9595)
- Caio César Alves Lins de Oliveira (ORCID: https://orcid.org/0000-0001-6218-2717)
- João Pedro Aguiar (ORCID: https://orcid.org/0000-0002-5799-3088)
Institutions
- University of Lisbon (PT)
- Universidade do Porto (PT)
- Hospital Vila Franca de Xira (PT)
Publication Details
- Journal
- International Journal of Clinical Pharmacy
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1007/s11096-025-01940-0
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- Universidade de Lisboa
- Fundação para a Ciência e a Tecnologia